A citation-based method for searching scientific literature

Nancy L Keating, Kathryn A Stoeckert, Meredith M Regan, Lisa DiGianni, Judy E Garber. J Clin Oncol 2008
Times Cited: 29







List of co-cited articles
149 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
L Wideroff, S T Vadaparampil, M H Greene, S Taplin, L Olson, A N Freedman. J Med Genet 2005
101
34

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
274
31

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
27


Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
178
24

Cancer genetic risk assessment and referral patterns in primary care.
Hetal S Vig, Joanne Armstrong, Brian L Egleston, Carla Mazar, Michele Toscano, Angela R Bradbury, Mary B Daly, Neal J Meropol. Genet Test Mol Biomarkers 2009
38
24

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
980
20

Physician use of genetic testing for cancer susceptibility: results of a national survey.
Louise Wideroff, Andrew N Freedman, Lorayn Olson, Carrie N Klabunde, William Davis, Kadaba P Srinath, Robert T Croyle, Rachel Ballard-Barbash. Cancer Epidemiol Biomarkers Prev 2003
91
20

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.
Sharon E Plon, H Paul Cooper, Bethany Parks, Shweta U Dhar, P Adam Kelly, Armin D Weinberg, Stephanie Staggs, Tao Wang, Susan Hilsenbeck. Genet Med 2011
74
20

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
647
20

A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
Tuya Pal, Deborah Cragun, Courtney Lewis, Andrea Doty, Maria Rodriguez, Cristi Radford, Zachary Thompson, Jongphil Kim, Susan T Vadaparampil. Genet Test Mol Biomarkers 2013
38
20


BRCA1/2 genetic testing in the community setting.
Wendy Y Chen, Judy E Garber, Suzanne Higham, Katherine A Schneider, Katie B Davis, Amie M Deffenbaugh, Thomas S Frank, Rebecca S Gelman, Frederick P Li. J Clin Oncol 2002
42
17

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
17

Errors in delivery of cancer genetics services: implications for practice.
Karina L Brierley, Danielle Campfield, Whitney Ducaine, Lindsay Dohany, Talia Donenberg, Kristen Shannon, Robin C Schwartz, Ellen T Matloff. Conn Med 2010
63
17


How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
Angela R Bradbury, James J Dignam, Comfort N Ibe, Sogyong L Auh, Fay J Hlubocky, Shelly A Cummings, Melody White, Olufunmilayo I Olopade, Christopher K Daugherty. J Clin Oncol 2007
58
13

Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Andrea Farkas Patenaude, Michel Dorval, Lisa S DiGianni, Katherine A Schneider, Anu Chittenden, Judy E Garber. J Clin Oncol 2006
117
13


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
771
13

Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
62
13

Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.
S U Dhar, H P Cooper, T Wang, B Parks, S A Staggs, S Hilsenbeck, S E Plon. Breast Cancer Res Treat 2011
21
19

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
137
13

A collaborative approach to genetic testing: a community hospital's experience.
Stephanie A Cohen, Dawn McIlvried, Julie Schnieders. J Genet Couns 2009
17
23


Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices.
Melanie F Myers, Man-Huei Chang, Cynthia Jorgensen, William Whitworth, Sidibe Kassim, James A Litch, Lori Armstrong, Barbara Bernhardt, W Andrew Faucett, Debra Irwin,[...]. Genet Med 2006
48
13

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
104
13

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
77
13


The "duty to warn" a patient's family members about hereditary disease risks.
Kenneth Offit, Elizabeth Groeger, Sam Turner, Eve A Wadsworth, Mary A Weiser. JAMA 2004
146
10

Learning of your parent's BRCA mutation during adolescence or early adulthood: a study of offspring experiences.
Angela R Bradbury, Linda Patrick-Miller, Kimberly Pawlowski, Comfort N Ibe, Shelly A Cummings, Fay Hlubocky, Olufunmilayo I Olopade, Christopher K Daugherty. Psychooncology 2009
34
10

Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors.
C Julian-Reynier, F Eisinger, F Chabal, C Lasset, C Noguès, D Stoppa-Lyonnet, P Vennin, H Sobol. Am J Med Genet 2000
72
10

Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
Jean Jenkins, Kathleen A Calzone, Eileen Dimond, David J Liewehr, Seth M Steinberg, Oxana Jourkiv, Pam Klein, Peter W Soballe, Sheila A Prindiville, Ilan R Kirsch. Genet Med 2007
47
10

Telemedicine and clinical genetics: establishing a successful service.
M R Gattas, J C MacMillan, I Meinecke, M Loane, R Wootton. J Telemed Telecare 2001
48
10


Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Esme Finlay, Jill E Stopfer, Eric Burlingame, Katherine Goldfeder Evans, Katherine L Nathanson, Barbara L Weber, Katrina Armstrong, Timothy R Rebbeck, Susan M Domchek. Genet Test 2008
96
10

Parent-child factors and their effect on communicating BRCA1/2 test results to children.
Kenneth P Tercyak, Beth N Peshkin, Tiffani A DeMarco, Barbara M Brogan, Caryn Lerman. Patient Educ Couns 2002
74
10



Psychosocial consequences of genetic counseling: a population-based follow-up study.
Ellen M Mikkelsen, Lone Sunde, Christoffer Johansen, Søren P Johnsen. Breast J 2009
12
25

Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Josephine Wagner Costalas, Mark Itzen, John Malick, James S Babb, Betsy Bove, Andrew K Godwin, Mary B Daly. Am J Med Genet C Semin Med Genet 2003
89
10

Results of a randomized study of telephone versus in-person breast cancer risk counseling.
Almut W Helmes, Julie O Culver, Deborah J Bowen. Patient Educ Couns 2006
48
10

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P Tercyak, Danielle Hanna, Claudine Isaacs,[...]. Am J Med Genet 2002
148
10

Family communication about positive BRCA1 and BRCA2 genetic test results.
Bobbi McGivern, Jessica Everett, Geoffrey G Yager, Robert C Baumiller, Amanda Hafertepen, Howard M Saal. Genet Med 2004
84
10


Telegenetic medicine: improved access to services in an underserved area.
H J Stalker, R Wilson, H McCune, J Gonzalez, M Moffett, R T Zori. J Telemed Telecare 2006
32
10

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
207
10

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
10

Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.
Joel Erblich, Karen Brown, Youngmee Kim, Heiddis B Valdimarsdottir, Barbara E Livingston, Dana H Bovbjerg. Patient Educ Couns 2005
42
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.